Lynx
San Diego, US · 4 known investors
Find your way into Lynx
LynxBio (Lynx Biosciences) is a biotech company developing immuno-oncology and immunology therapies using a proprietary patient-based ex vivo disease biology platform combined with a multiomics approach for drug discovery. It partners with biopharmaceutical and technology companies to identify therapeutic candidates while advancing its own internal pipeline.
Founders & leadership
CP
Chorom PakinCEO/Founder
Investors · 4
Checkmate Capital Group LLCPasadena
Cove FundIrvine · $250K – $1M
Flare Capital PartnersreportedBoston · $1M – $10M
Also in the syndicate · 1
Somnium Spacelead
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AFeb 2025Source ↗
- Undisclosed amountSeries ANov 2023Source ↗
- Undisclosed amountSeries AMay 2022
Somnium Space (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Lynx do?
- LynxBio (Lynx Biosciences) is a biotech company developing immuno-oncology and immunology therapies using a proprietary patient-based ex vivo disease biology platform combined with a multiomics approach for drug discovery. It partners with biopharmaceutical and technology companies to identify therapeutic candidates while advancing its own internal pipeline.
- Who founded Lynx?
- Lynx was founded by Chorom Pak.
- Who are Lynx's investors?
- Lynx's investors include Checkmate Capital Group LLC, Cove Fund, Flare Capital Partners.
- Where is Lynx headquartered?
- Lynx is headquartered in San Diego, US.